Insider · CIK 0001210622

CROWELL NANCY M

Reports to the SEC for 2 companies · LINCOLNSHIRE, IL

sec.gov

Transactions

Companies

Filings

CIK

0001210622

Forms 4 and 5

Insider transactions

24 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2009-10-14	CELL GENESYS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2009-10-14	CELL GENESYS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2009-10-14	CELL GENESYS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2009-10-14	CELL GENESYS INCStock Option (right to buy0D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2009-10-14	CELL GENESYS INCD Disposition to Issuer	Director	DDisposition to Issuer	−8,000 sh	—	—	0
2009-10-14	CELL GENESYS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2009-10-14	CELL GENESYS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2009-10-14	CELL GENESYS INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2009-10-14	CELL GENESYS INCStock Option (right to buy0D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2007-06-29	CELL GENESYS INCA Award	Director	AAward	+4,000 sh	—	—	4,000
2007-06-29	CELL GENESYS INCStock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2007-01-26	RENOVIS INCStock Option (right to buy)A Award	Director	AAward	+11.1K sh	—	—	11,111
2006-06-30	CELL GENESYS INCStock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	$5.02	+$37.7K	7,500
2006-01-16	RENOVIS INCStock Option (Right to buy)A Award	Director	AAward	+11.1K sh	—	—	11,111
2005-06-30	CELL GENESYS INCStock Option (right to buy)A Award	Director	AAward	+7,500 sh	$5.35	+$40.1K	60,000
2005-05-09	RENOVIS INCS Sale	Director	SSale	−68 sh	$15.47	−$1,051.96	47,312
2005-02-09	RENOVIS INCStock Option (Right to buy)A Award	Director	AAward	+11.1K sh	—	—	11,111
2004-02-10	RENOVIS INCC Conversion	Director	CConversion	+47.4K sh	—	—	47,380
2004-02-10	RENOVIS INCC Conversion	Director	CConversion	+784K sh	—	—	783,850
2004-02-10	RENOVIS INCSeries C Preferred StockC Conversion	Director	CConversion	−97.2K sh	—	—	0
2004-02-10	RENOVIS INCSeries C Preferred StockC Conversion	Director	CConversion	−1.61M sh	—	—	0
2004-02-10	RENOVIS INCSeries E Preferred StockC Conversion	Director	CConversion	−116K sh	—	—	0
2004-02-10	RENOVIS INCSeries E Preferred StockC Conversion	Director	CConversion	−1.92M sh	—	—	0
2002-06-28	CELL GENESYS INCNon-Qualified Stock Option (right to buy) (1)A Award	Director	AAward	+7,500 sh	—	—	—

Recent filings

Accepted (ET)
Oct 154
CROWELL NANCY M0001235802-09-000104
SEC(opens sec.gov)
Jul 34
CELL GENESYS INC0001209191-07-040432
SEC(opens sec.gov)
Jan 304
RENOVIS INC0001181431-07-006978
SEC(opens sec.gov)
Jun 304
CROWELL NANCY M0001209191-06-038931
SEC(opens sec.gov)
May 24/A
RENOVIS INC0001181431-06-027060
SEC(opens sec.gov)
Jan 184
CROWELL NANCY M0001181431-06-004130
SEC(opens sec.gov)
Jul 14
CROWELL NANCY M0000865231-05-000032
SEC(opens sec.gov)
Feb 164
RENOVIS INC0001181431-05-010385
SEC(opens sec.gov)
Feb 114
CROWELL NANCY M0001181431-04-008027
SEC(opens sec.gov)

Companies

Address

C/O BIOSANTE PHARMACEUTICALS, INC. 111 BARCLAY BOULEVARD, SUITE 280

LINCOLNSHIRE, IL, 60069